The clinical and laboratory findings in patients with severe COVID-19 are indicative of macrophage activation syndrome (40), which occurs in diverse clinical settings and is characterized by elevated CRP, IL-6 and other inflammatory cytokines, suggesting that the immunopathology of severe COVID-19 involves dysregulation of macrophage homeostasis. This evidence concerns the gene IL6 and COVID-19.